« Best Poster Award Given to Prasun Guha at the National Institutes of Health Glyco Meeting | Main | Dr. Allen Place honored with Presidents Award for Science Application »

Dr. Shiladitya DasSarma has received a $100,000 grant to develop an oral vaccine in a salt shaker.

Shiladitya DasSarma, Ph.D. has won a grant from Grand Challenges Explorations, an initiative funded by the Bill & Melinda Gates Foundation. He will pursue an innovative global health and development research project titled “Vaccine in a Salt Shaker: A New, Safe, Low-Cost Approach,” with the $100,000 grant.

Grand Challenges Explorations (GCE) funds individuals worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges. Dr. DasSarma’s project is one of more than 100 Grand Challenges Explorations Round 8 grants announced today by the Bill & Melinda Gates Foundation.

“Grand Challenges Explorations encourages individuals worldwide to expand the pipeline of ideas where creative, unorthodox thinking is most urgently needed,” said Chris Wilson, director of Global Health Discovery and Translational Sciences at the Bill & Melinda Gates Foundation. “We’re excited to provide additional funding for select grantees so that they can continue to advance their idea towards global impact.”

To receive funding, Dr. DasSarma and other Grand Challenges Explorations Round 8 winners demonstrated in a two-page online application a bold idea in one of five critical global heath and development topic areas that included agriculture development, immunization and nutrition. Applications for the current open round, Grand Challenges Explorations Round 9, will be accepted through May 15, 2012.

Dr. DasSarma’s project utilizes novel microbes known as Haloarchaea, which can be packaged in salt crystals, as a system for delivery of antigens of pathogenic microorganisms. The approach has certain advantages, such as the ability to produce large quantities of vaccine inexpensively, simple oral administration, no need for refrigeration, and ease of distribution in remote locations worldwide.

He will lead a team of researchers at the University of Maryland School of Medicine, along with international collaborators, to develop an inexpensive, safe and effective oral vaccine against invasive Salmonella disease. Dr. DasSarma’s laboratory is located at the University System of Maryland’s Institute for Marine and Environmental Technology in the Columbus Center in Baltimore’s Inner Harbor.

About

This page contains a single entry from the blog posted on June 25, 2012 10:46 AM.

The previous post in this blog was Best Poster Award Given to Prasun Guha at the National Institutes of Health Glyco Meeting.

The next post in this blog is Dr. Allen Place honored with Presidents Award for Science Application.

Many more can be found on the main index page or by looking through the archives.

Powered by
Movable Type 3.34